DataPathology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DataPathology - overview
Established
2020
Location
Casablanca, -, Morocco
Primary Industry
Healthcare IT
About
Based in Casablanca, Morocco, and founded in 2020, Data Pathology is made up of pathologists and digital specialists that develop and markets digital solutions to help its customers deliver pathological diagnoses remotely and faster. The company Dr. Hicham El Attar and Mr. Mohammed El Khannoussi.
In September 2021, Data Pathology raised USD 232,000 in Venture funding led by WitamaxOne, with participation from Southbridge A&I and AXXAM. Data Pathology offers digital solutions e-PATH a digital platform that allows laboratories to share slides and the results of the Pathological diagnosis, Scanning slides that assist users to set up their own slide scanners, and eye-PATH is an artificial intelligence module to aid in the diagnosis of pathologies such as breast cancer and tuberculosis. The company's digital and pathology specialists support users in study and advice, integration, medical advice, training in telepathology, and research in pathological anatomy. The organization plans to use the September 2021 funding to transform the pathological diagnosis system and improve the services provided to practitioners and patients.
Current Investors
AXXAM, Witamax, Southbridge A&I
Primary Industry
Healthcare IT
Sub Industries
Consulting Services, Healthcare IT, Medical Software, Application Integration Software
Website
www.datapathology.ma
Verticals
Artificial Intelligence, HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
DataPathology - timeline of key events

DataPathology - financials
| Fiscal Year Ended | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|
| Revenue (USD) | - | - |
| % Revenue Growth (YoY) | - | - |
| EBITDA (USD) | - | - |
| Operating Income (USD) | - | - |
| Operating Margin | - | - |
| % EBITDA Margin | - | - |
| NET Income (USD) | - | - |
| % Net Margin | - | - |
DataPathology - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.